US equities
|
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
NVDA
$215.38
▼-1.17%
GOOGL
$324.89
▲+1.34%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
MSFT
$531.01
▼-0.06%
SNDK
$1,404.77
▲+7.66%
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
NVDA
$215.38
▼-1.17%
GOOGL
$324.89
▲+1.34%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
MSFT
$531.01
▼-0.06%
SNDK
$1,404.77
▲+7.66%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about #covid/19
Recent news which mentions #covid/19
The Path to Job Mobility
February 11, 2022
Tickers
MA
Tags
Mastercard Center for Inclusive Growth
#FinancialInclusion
mastercard
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine
December 17, 2021
Tickers
MRK
Tags
Merck & Co
#covid/19
Responsible Production & Consumption
From
3BL Media: Corporate Social Responsibility, Energy and Health News